Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,600 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 4 January 2021) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

 (PDF, 3MB, 218 pages) 

This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website. 

 

 

Export 91 results:
Author Title Type [ Year(Asc)]
Filters: Author is Suissa, S.  [Clear All Filters]
2020
F. Khosrow-Khavar, Filion, K. B., Bouganim, N., Suissa, S., and Azoulay, L., “Aromatase Inhibitors and the Risk of Cardiovascular Outcomes in Women With Breast Cancer: A Population-Based Cohort Study”, Circulation, vol. 141, pp. 549-559, 2020.
F. Giorgianni, Ernst, P., Dell'Aniello, S., Suissa, S., and Renoux, C., “Beta 2 agonists and the incidence of Parkinson's disease”, Am J Epidemiol, 2020.
F. Khosrow-Khavar, Bouganim, N., Filion, K. B., Suissa, S., and Azoulay, L., “Cardiotoxicity of Sequential Aromatase Inhibitors Use in Women with Breast Cancer”, Am J Epidemiol, 2020.
T. Tran and Suissa, S., “Comparing New-User Cohort Designs: The Example of Proton Pump Inhibitor Effectiveness in Idiopathic Pulmonary Fibrosis”, Am J Epidemiol, 2020.
T. Tran, Assayag, D., Ernst, P., and Suissa, S., “Effectiveness of proton pump inhibitors in idiopathic pulmonary fibrosis: a population-based cohort study”, Chest, 2020.
2019
F. Montastruc, Nie, R., Loo, S., Rej, S., Dell'Aniello, S., Micallef, J., Suissa, S., and Renoux, C., “Association of Aripiprazole With the Risk for Psychiatric Hospitalization, Self-harm, or Suicide”, JAMA Psychiatry, 2019.
A. Douros, Dell'Aniello, S., Yu, O. H. Y., and Suissa, S., “Comparative cardiovascular and hypoglycemic safety of glimepiride in type 2 diabetes: A population-based cohort study”, Diabetes Obes Metab, 2019.
S. Suissa, Dell'Aniello, S., and Ernst, P., “Comparative effectiveness and safety of LABA-LAMA versus LABA-ICS treatment of COPD in real world clinical practice”, Chest, 2019.
S. Suissa, Dell'Aniello, S., and Ernst, P., “Comparative effects of LAMA-LABA-ICS versus LAMA-LABA for COPD: Cohort study in real world clinical practice: LAMA-LABA-ICS versus LAMA-LABA in COPD”, Chest, 2019.
K. B. Filion, Douros, A., Azoulay, L., Yin, H., Yu, O. H., and Suissa, S., “Sulfonylureas as initial treatment for type 2 diabetes and the risk of adverse cardiovascular events: A population-based cohort study”, Br J Clin Pharmacol, 2019.
2018
L. Sinyavskaya, Gauthier, S., Renoux, C., Dell'Aniello, S., Suissa, S., and Brassard, P., “Comparative effect of statins on the risk of incident Alzheimer disease”, Neurology, vol. 90, pp. e179-e187, 2018.
S. Suissa, Dell'Aniello, S., and Ernst, P., “Comparative effectiveness of LABA-ICS versus LAMA as initial treatment in COPD targeted by blood eosinophils: a population-based cohort study”, Lancet Respir Med, vol. 6, pp. 855-862, 2018.
S. Y. Loo, Coulombe, J., Dell'Aniello, S., Brophy, J. M., Suissa, S., and Renoux, C., “Comparative effectiveness of novel oral anticoagulants in UK patients with non-valvular atrial fibrillation and chronic kidney disease: a matched cohort study”, BMJ Open, vol. 8, p. e019638, 2018.
H. A. Abenhaim, Tulandi, T., Wilchesky, M., Platt, R., Spence, A. R., Czuzoj-Shulman, N., and Suissa, S., “Effect of Cesarean Delivery on Long-term Risk of Small Bowel Obstruction”, Obstet Gynecol, vol. 131, pp. 354-359, 2018.
O. Yu, Azoulay, L., Yin, H., Filion, K. B., and Suissa, S., “Sulfonylureas as Initial Treatment for Type 2 Diabetes and the Risk of Severe Hypoglycemia”, Am J Med, vol. 131, pp. 317.e11-317.e22, 2018.
A. Douros, Dell'Aniello, S., Yu, O. H. Y., Filion, K. B., Azoulay, L., and Suissa, S., “Sulfonylureas as second line drugs in type 2 diabetes and the risk of cardiovascular and hypoglycaemic events: population based cohort study”, Bmj, vol. 362, p. k2693, 2018.
2017
C. Renoux, Dell'Aniello, S., Brenner, B., and Suissa, S., “Bias from depletion of susceptibles: the example of hormone replacement therapy and the risk of venous thromboembolism”, Pharmacoepidemiol Drug Saf, vol. 26, pp. 554-560, 2017.
S. Suissa, Dell'Aniello, S., and Ernst, P., “Concurrent use of long-acting bronchodilators in COPD and the risk of adverse cardiovascular events”, Eur Respir J, vol. 49, 2017.
N. Larivee, Suissa, S., Eberg, M., Joseph, L., Eisenberg, M. J., Abenhaim, H. A., and Filion, K. B., “Drospirenone-containing combined oral contraceptives and the risk of arterial thrombosis: a population-based nested case-control study”, Bjog, vol. 124, pp. 1672-1679, 2017.
N. Larivee, Suissa, S., Coulombe, J., Tagalakis, V., and Filion, K. B., “Drospirenone-Containing Oral Contraceptive Pills and the Risk of Venous Thromboembolism: An Assessment of Risk in First-Time Users and Restarters”, Drug Saf, vol. 40, pp. 583-596, 2017.
P. Brassard, Wu, J. W., Ernst, P., Dell'Aniello, S., Smiechowski, B., and Suissa, S., “The effect of statins on influenza-like illness morbidity and mortality”, Pharmacoepidemiol Drug Saf, vol. 26, pp. 63-70, 2017.
S. Suissa, Dell'Aniello, S., and Ernst, P., “Long-Acting Bronchodilator Initiation in COPD and the Risk of Adverse Cardiopulmonary Events: A Population-Based Comparative Safety Study”, Chest, vol. 151, pp. 60-67, 2017.
J. W. Wu, Azoulay, L., Majdan, A., Boivin, J. F., Pollak, M., and Suissa, S., “Long-Term Use of Long-Acting Insulin Analogs and Breast Cancer Incidence in Women With Type 2 Diabetes”, J Clin Oncol, vol. 35, pp. 3647-3653, 2017.
B. M. Hicks, Yin, H., Sinyavskaya, L., Suissa, S., Azoulay, L., and Brassard, P., “Metformin and the incidence of viral associated cancers in patients with type 2 diabetes”, Int J Cancer, vol. 141, pp. 121-128, 2017.
A. Douros, Yin, H., Yu, O. H. Y., Filion, K. B., Azoulay, L., and Suissa, S., “Pharmacologic Differences of Sulfonylureas and the Risk of Adverse Cardiovascular and Hypoglycemic Events”, Diabetes Care, vol. 40, pp. 1506-1513, 2017.
S. Suissa, Moodie, E. E., and Dell'Aniello, S., “Prevalent new-user cohort designs for comparative drug effect studies by time-conditional propensity scores”, Pharmacoepidemiol Drug Saf, vol. 26, pp. 459-468, 2017.
2016
Y. Lian, Yin, H., Pollak, M. N., Carrier, S., Platt, R. W., Suissa, S., and Azoulay, L., “Phosphodiesterase Type 5 Inhibitors and the Risk of Melanoma Skin Cancer”, Eur Urol, vol. 70, pp. 808-815, 2016.
C. Renoux, Shin, J. Y., Dell'Aniello, S., Fergusson, E., and Suissa, S., “Prescribing trends of attention-deficit hyperactivity disorder (ADHD) medications in UK primary care, 1995-2015”, Br J Clin Pharmacol, vol. 82, pp. 858-68, 2016.
K. Tascilar, Dell'Aniello, S., Hudson, M., and Suissa, S., “Statins and Risk of Rheumatoid Arthritis: A Nested Case-Control Study”, Arthritis Rheumatol, vol. 68, pp. 2603-2611, 2016.
C. Martinez, Suissa, S., Rietbrock, S., Katholing, A., Freedman, B., Cohen, A. T., and Handelsman, D. J., “Testosterone treatment and risk of venous thromboembolism: population based case-control study”, Bmj, vol. 355, p. i5968, 2016.
K. Tascilar, Azoulay, L., Dell'Aniello, S., Bartels, D. B., and Suissa, S., “The Use of Telmisartan and the Incidence of Cancer”, Am J Hypertens, vol. 29, pp. 1358-1365, 2016.
2015
O. H. Yu, Filion, K. B., Azoulay, L., Patenaude, V., Majdan, A., and Suissa, S., “Incretin-based drugs and the risk of congestive heart failure”, Diabetes Care, vol. 38, pp. 277-84, 2015.
J. P. Fournier, Azoulay, L., Yin, H., Montastruc, J. L., and Suissa, S., “Tramadol use and the risk of hospitalization for hypoglycemia in patients with noncancer pain”, JAMA Intern Med, vol. 175, pp. 186-93, 2015.
F. Lapi, Azoulay, L., Kezouh, A., Benisty, J., Matok, I., Mugelli, A., and Suissa, S., “The use of antidepressants and the risk of chronic atrial fibrillation”, J Clin Pharmacol, vol. 55, pp. 423-30, 2015.
2014
S. Dial, Nessim, S. J., Kezouh, A., Benisty, J., and Suissa, S., “Antihypertensive agents acting on the renin-angiotensin system and the risk of sepsis”, Br J Clin Pharmacol, vol. 78, pp. 1151-8, 2014.
S. Couraud, Azoulay, L., Dell'Aniello, S., and Suissa, S., “Cardiac glycosides use and the risk of lung cancer: a nested case-control study”, BMC Cancer, vol. 14, p. 573, 2014.
J. P. Fournier, Duijnhoven, R. G., Renoux, C., Dell'Aniello, S., Klungel, O. H., and Suissa, S., “Concurrent use of statins and hormone therapy and risk of venous thromboembolism in postmenopausal women: a population-based case-control study”, Menopause, vol. 21, pp. 1023-6, 2014.
I. Matok, Azoulay, L., Yin, H., and Suissa, S., “Immortal time bias in observational studies of drug effects in pregnancy”, Birth Defects Res A Clin Mol Teratol, vol. 100, pp. 658-62, 2014.
J. L. Faillie, Azoulay, L., Patenaude, V., Hillaire-Buys, D., and Suissa, S., “Incretin based drugs and risk of acute pancreatitis in patients with type 2 diabetes: cohort study”, Bmj, vol. 348, p. g2780, 2014.
L. Azoulay, Dell'Aniello, S., Simon, T. A., Renoux, C., and Suissa, S., “Initiation of warfarin in patients with atrial fibrillation: early effects on ischaemic strokes”, Eur Heart J, vol. 35, pp. 1881-7, 2014.
L. Huiart, Ferdynus, C., Dell'Aniello, S., Bakiri, N., Giorgi, R., and Suissa, S., “Measuring persistence to hormonal therapy in patients with breast cancer: accounting for temporary treatment discontinuation”, Pharmacoepidemiol Drug Saf, vol. 23, pp. 882-9, 2014.
L. Bensimon, Yin, H., Suissa, S., Pollak, M. N., and Azoulay, L., “Type 2 diabetes and the risk of mortality among patients with prostate cancer”, Cancer Causes Control, vol. 25, pp. 329-38, 2014.
B. D. Fox, Azoulay, L., Dell'Aniello, S., Langleben, D., Lapi, F., Benisty, J., and Suissa, S., “The use of antidepressants and the risk of idiopathic pulmonary arterial hypertension”, Can J Cardiol, vol. 30, pp. 1633-9, 2014.
2013
F. Lapi, Azoulay, L., Niazi, M. T., Yin, H., Benayoun, S., and Suissa, S., “Androgen deprivation therapy and risk of acute kidney injury in patients with prostate cancer”, Jama, vol. 310, pp. 289-96, 2013.
J. Assayag, Yin, H., Benayoun, S., Pollak, M. N., Suissa, S., and Azoulay, L., “Androgen deprivation therapy and the risk of colorectal cancer in patients with prostate cancer”, Cancer Causes Control, vol. 24, pp. 839-45, 2013.
L. Azoulay, Dell'Aniello, S., Simon, T., Renoux, C., and Suissa, S., “The concurrent use of antithrombotic therapies and the risk of bleeding in patients with atrial fibrillation”, Thromb Haemost, vol. 109, pp. 431-9, 2013.
F. Lapi, Azoulay, L., Yin, H., Nessim, S. J., and Suissa, S., “Concurrent use of diuretics, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers with non-steroidal anti-inflammatory drugs and risk of acute kidney injury: nested case-control study”, Bmj, vol. 346, p. e8525, 2013.
B. Smiechowski, Azoulay, L., Yin, H., Pollak, M. N., and Suissa, S., “The use of metformin and colorectal cancer incidence in patients with type II diabetes mellitus”, Cancer Epidemiol Biomarkers Prev, vol. 22, pp. 1877-83, 2013.
B. B. Smiechowski, Azoulay, L., Yin, H., Pollak, M. N., and Suissa, S., “The use of metformin and the incidence of lung cancer in patients with type 2 diabetes”, Diabetes Care, vol. 36, pp. 124-9, 2013.
2012
C. Renoux, Dell'Aniello, S., Brophy, J. M., and Suissa, S., “Dopamine agonist use and the risk of heart failure”, Pharmacoepidemiol Drug Saf, vol. 21, pp. 34-41, 2012.
[Page last reviewed 5 January 2021]